Halcon Resources is leveraging an experienced staff and the most advanced technology available to grow its influence in the oil and gas industry. The relatively young company is focused on the acquisition, production, exploration and development of onshore liquids-rich assets in the United States, particularly at its two core operations in North Dakota and Texas.

The first of the company’s primary operations is located within one of the most promising reserves in the country: the Bakken Formation. As of the end of 2014, Halcon held approximately 129,000 acres throughout the state, and early results have been promising. This year, the company expects to begin drilling operations for 25 to 30 new wells in the Williston Basin. According to the U.S. Energy Information Administration, the region’s production climbed to nearly 600,000 barrels per day in 2012, highlighting the extreme production potential of the basin that’s been unlocked by modern drilling technology.

El Halcon, the company’s second core operation, is located in the most active shale play in the world, the Eagle Ford Shale Formation of East Texas. Halcon plans to begin drilling operations on 12 to 15 operated wells this year. This play could provide Halcon with potentially massive increases in production capacity. In March 2015, the region’s production totals climbed to 1.6 million daily barrels, according to Fuel Fix.

With operations in two of the country’s most promising regions, as well as a collection of non-core plays around the nation, Halcon is in a strong position to increase its market share in the competitive industry. Following the release of the company’s Q1 2015 financial results, industry analysts were optimistic about the potential for strong growth moving forward. In addition to dramatic decreases in operating costs, Halcon was able to meet its average production goals for the period, netting just over 43,000 barrels of oil equivalent per day.

Led by proven Chairman and Chief Executive Officer Floyd Wilson, former Petrohawk President and CEO, analysts agree that the company has made significant steps towards growth in recent months. With a rapidly improving balance sheet and sufficient liquidity “to fund operations… for the next several years,” according to Wilson, Halcon is embracing the vision and agility needed to become a resource powerhouse in the oil and gas industry. As the market appears to be headed toward a lasting shift in both prices and production targets, look for Halcon to continue making waves in the years to come.

For more information, visit www.halconresources.com

Stellar Biotech is the industry leader in the field of sustainably manufacturable Keyhole Limpet Hemocyanin, or KLH, a revolutionary pharmaceutical protein derived from a scarce species of limpet that only lives in the northeast Pacific, Megathura crenulata, more commonly known as the great or giant keyhole limpet. The exceedingly complex structure and size of the KLH molecule has placed it well beyond the capabilities of even the most advanced synthetic production technologies, meaning the only source for this extremely useful carrier protein is this scarce organism, which lives in only one region of the earth’s waters, an increasingly endangered ocean habitat. KLH is already in use across a wide variety of both research and therapeutic vaccine applications whenever developers can get their hands on enough of the stuff, due to a significant litany of advantages offered by the molecule which simply cannot be found elsewhere or replicated using synthetic alternatives.

What really sets Stellar apart within this niche industry is their world-leading, proprietary aquaculture technology that allows them to sustainably farm giant keyhole limpets and extract an abundant supply of GMP-grade Stellar KLH™ without harming the organism. KLH is eagerly sought after for its ability to carry peptides, typically small proteins of low molecular weight and other drug molecules that do not elicit an immune response on their own. Some of the most significant advantages of this molecule as a carrier protein are its established track record of being extremely safe in the human body, an exceptionally large molecular size with numerous epitope (the part of an antigen that is recognized by the immune system) binding sites for maximized antigen conjugation, and a proven ability to function as a high-efficiency carrier in multiple different applications.

With the granting of an FDA Breakthrough Therapy Designation for a KLH-based immunotherapy compound earlier this year in March, developed by Celldex Therapeutics (NASDAQ: CLDX), which is studying its application in adults suffering from a type of brain cancer known as GBM (EGFRvIII-positive glioblastoma), Stellar Biotechnologies (OTC: SBOTF) (TSXV: KLH) is now extremely well positioned, given that this will likely turn out to be one of the historically most important milestones for validating the KLH-conjugate approach in immunotherapy. The company is aggressively moving to strengthen its overall market presence and really capitalize on the emerging realization throughout the industry of the vast potential of this immune-stimulating protein, and its potential applications across a whole host of immunotherapeutic markets.

The company has now announced a crucial move to up-sell KLH into said markets through a greatly expanded online presence, pushing the company’s corporate communications channels further out into the realm of social media, with a concerted effort to provide the relevant educational content and information about Stellar’s game-changing technology, as well as keeping everyone updated on the company’s constant innovations and activities. The plan is to branch out from the main corporate site www.stellarbiotech.com, leveraging the enormous wealth of scientific and clinical data compiled at www.klhsite.org, in order to establish a bold presence across the three main social media vectors. Google’s (NASDAQ: GOOGL) rapidly growing Google+ framework, which is arguably one of the best ways to increase search visibility in the business world due to its native dovetailing with Google’s ever-changing algorithms, via the “+StellarBiotech” handle, as well as through the still enormously popular venue Facebook (NASDAQ:FB) via the company’s www.facebook.com/StellarBiotech page, and of course by using Twitter (NYSE:TWTR), via their @StellarBiotech account.

Keeping investors and key industry players alike up to date through consistent communication of the company’s activities, as well as routinely pushing relevant data regarding industry developments and the important role Stellar’s KLH technology plays, will no doubt be fundamentally important to the company’s overall marketing strategy. Investors should keep a close eye on Stellar Biotechnologies as their social media footprint takes shape and KLH cements an increasingly frontline role in immunotherapy.

For more information, visit www.stellarbiotechnologies.com

Growblox Sciences, a biopharmaceutical research and development company, is focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies for various medical conditions. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

The company’s GrowBLOX technology suite includes the TissueBLOX, GrowBLOX, and CureBLOX equipment. Together, these components provide unparalleled control and monitoring of cannabis cultivation throughout the plant’s life-cycle. These patent pending processes were designed to produce a safe and consistent cannabis product under cGMP guidelines. Utilizing a computer-regulated system that optimizes the nutrients, water, temperature, and gas levels, the GrowBLOX suite produces cannabis with more active ingredients per pound than traditional cultivation methods.

Also, based on an analysis of preclinical and clinical data from thousands of peer-reviewed studies, Growblox Sciences has identified the most effective profiles of cannabinoids and terpenes for the treatment of conditions within seven therapeutic categories. As a result of this extensive research and the analysis of the active ingredient profiles of 30,000 Cannabis strains in conjunction with a major testing lab, the company will be able to provide patients with natural cannabis strains containing the ideal ratios for treating specific diseases or symptoms.

Another significant advantage held by the company stems from an accelerated drug development program to finish in 3-5 years instead of the 15-20 years typically seen in traditional pharmaceutical development programs. Armed with an intellectual property strategy that takes full advantage of the design of the GrowBLOX technology suite and protects the valuable foundation laid, Growblox Sciences has positioned itself well for long-term success in the burgeoning cannabis space.

For more information, visit www.growblox.com

Let us hear your thoughts: Growblox Sciences, Inc. Message Board

Modern electronic devices are often sold on the principle of mobility, and that principle is a gripping prospect for an expanding number of consumers. As evidence, consider that, as of October 2014, an estimated 64 percent of American adults owned a smartphone, according to Pew Research Center. Despite the promise of mobility, however, personal electronic devices continue to be limited by a common factor: power. According to Geek.com, a typical smartphone provides users with approximately five hours of talk time, but these figures are greatly diminished with other activity, including gaming or surfing the web. So, how can electronic devices ditch the wires and deliver on the promise of true mobility? Energous Corp. (NASDAQ: WATT), through its WattUp™ transmitter, is providing the solution.

With its proprietary product ecosystem, Energous allows users to charge any battery-operated device that requires less than 10 watts (cell phones, tablets, wearables, cameras, etc.) through a radio frequency (RF) signal. Similar to a Wi-Fi system, WattUp™ delivers safe wire-free energy to devices up to 15 feet away from the transmitting device. With compatibility for up to 12 devices simultaneously managed by a single system, it provides a safe and efficient solution to the classic power conundrum.

In addition to its revolutionary hardware, the WattUp™ system utilizes a customizable mobile app interface to allow for device prioritization based on users’ charging needs. Using the software, a consumer could set household devices to charge while he or she was away, while placing the focus on cell phones and tablets after work. This functionality could make thoughts of charging devices a thing of the past.

In addition to personal offerings, Energous is currently seeking target destinations for ubiquitous wire-free power outside of the home. High traffic commercial locations, including coffee shops, restaurants, metro stops, malls and airports, are all currently on the company’s radar of potentially suitable areas for initial efforts. Through the engagement of key infrastructure providers and operators, the company has access to historically relevant data from the delivery of similar services (e.g. paid Wi-Fi zones) to the market, giving Energous a significant advantage in analyzing market potential.

The demand for increased mobility is on the rise, as can be seen by the 350 percent increase in global public Wi-Fi hotspots over the past four years, according to the Wireless Broadband Alliance. Wireless power currently stands as the last significant restriction on full mobility, ensuring that the wire-free charging industry will maintain significant demand moving forward. With plans in place for both public and private applications of the WattUp™ product line, Energous looks to be set for tremendous growth opportunities in the years to come.

For more information, visit www.energous.com

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain, inflammation and pruritus. The company’s most advanced candidate, CR845, is a patented compound possessing analgesic, anti-inflammatory and anti-pruritic activities that make it appropriate for a variety of therapeutic applications. Currently, the compound is undergoing clinical testing for the treatment of acute pain and pruritus.

“The first half of 2015 continues to be an important period for the Company as we finalize and initiate our Phase 3 Program for I.V. CR845, which offers the potential for post-operative pain relief without typical opioid side effects,” stated Dr. Derek Chalmers, President and Chief Executive Officer of Cara.

The demand for pain medications throughout the United States is considerable. According to IMS Health, the total market for pain management pharmaceuticals throughout the country accounted for $18.2 billion in 2012. Despite its size, however, the pain and inflammation market currently represents an area with substantial unmet patient need. This is because the majority of existing pain medications are severely limited by a host of adverse side effects. The potentially negative effects of opioids, which are currently the most common treatment for moderate-to-severe pain, include diminished effectiveness over time, potential for addiction and nausea, among others.

Cara’s CR845 possesses peripherally-selective molecules that interact with the kappa opioid receptors located directly on pain-sensing nerves. In early testing, the compound has been shown as extremely effective in terms of kappa receptor selectivity and has shown no significant affinity for non-opioid receptors. If these results prove to be consistent throughout clinical testing, the drug candidate should produce a similar pain management effect to currently available options without many of the dangerous side effects.

According to a report from ABC News, while the United States makes up only 4.6 percent of the world’s population, as much as 80 percent of the world’s opioids are consumed within the country. This statistics shows the incredible demand for painkilling medications, but experts also suggest that it is an indicator of the overall addictiveness of currently available drugs. Cara, through the continued development of CR845, is both addressing the issue of addictiveness and positioning itself for substantial growth in the pharmaceutical market moving forward.

With hydrocodone combination products being moved from the more-permissive Schedule III to the restrictive Schedule II category in the United States late last year, the market may soon be on the hunt for a more easily accessible alternative to the country’s most widely-prescribed pills. If CR845 receives a “lower scheduled or potentially even non-scheduled designation” at the conclusion of trials, as has been previously suggested by Dr. Chalmers, Cara is in a strong strategic position to make a substantial impact on the biopharmaceutical industry for years to come.

For more information, visit www.caratherapeutics.com

IFAN Financial, a designer, developer, and distributer of software to enable mobile payments, has been selected by Blue Like Neon to provide the digital branding agency with cutting-edge mobile payments solutions.

Blue Like Neon utilizes a multi-pronged market enhancement strategy designed to create campaigns that allow clients to better engage with their customers while increasing visibility and retention. IFAN Financial will deploy its mobile gateway to enhance this approach by providing Blue Like Neon with a social commerce platform that can be customized for each client’s unique needs.

“We believe the days of a ‘one size fits all’ approach to mobile commerce are over. Blue Like Neon is one of the leaders in providing the next generation of user experiences in the digital domain and we are honored to have been selected by them as an industry partner,” IFAN Financial’s president and CEO, J. Christopher Mizer, stated in the news release.

Blue Like Neon’s founding partner, Landis White, further explained how IFAN’s technology will complement the company’s existing platform.

“The flexibility and security features of IFAN’s solutions are very appealing to us and our clients. IFAN’s payment solution allows us to integrate state-of-the-art technology into the app and e-commerce architecture. The end result increases convenience and security while lowering costs. We view this as providing a significant competitive advantage,” White stated.

For more information, visit http://ifanfinancial.com

Let us hear your thoughts: IFAN Financial, Inc. Message Board

Nearly everyone has a smartphone, and the capabilities of these revered devices is seemingly endless. But it wasn’t always so. In the early 2000s, the most extravagant cellphone features included email, fax and web browsing. Since then advancement has been rampant, and today you can use smartphones to video message someone on the other side of the world, pay your utility bills, or remotely control your home lighting system. The sky is the limit.

Consorteum Holdings has spent the last three years of the technological evolution developing relationships and licensing agreements needed to compete in the emerging mobile gaming market.

Through its mix of on-deck partnerships, license agreements and joint-venture revenue share arrangements, the company specializes in utilizing smartphone capabilities for the delivery of mobile content, mobile payment solutions and other products.

Consorteum’s approach is designed to enable ultimate flexibility when sourcing solutions to achieve smarter, faster deployment of technologies, competitive pricing, and the potential for new streams of revenue.

The company’s ThreeFiftyNine Inc. subsidiary is working with a software development team that previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The result of years of development and millions of engineering costs, the platform is the first generation software delivery platform for mobile devices. The technology is capable of delivering any digital content across any cellular network to any mobile device, a key differentiator that makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.

As the broader smartphone and technology industries continue to evolve in application and capability, Consorteum is pursuing mobile initiatives that benefit multiple business verticals. The company has designed its business initiatives to create repetitive transactions on an ongoing basis.

For more information, visit www.consorteum.com

Let us hear your thoughts: Consorteum Holdings, Inc. Message Board

Dolls make up one of the largest chunks of the roughly $22 billion U.S. market for traditional toys at around 10.5% of the overall space. Dolls did roughly $2.22 billion in 2013 and approximately $2.32 billion last year, representing a four percent growth rate according to market research company NPD Group’s (formerly National Purchase Diary) consumer panel tracking data, which is published by the Toy Industry Association. NPD Group is consistently ranked as one of the top 25 companies on the annual Honomichl Top 50 report covering Fortune 500 market research firms and thus the above data, which represents roughly 80% of the U.S. retail toy market, gives investors a very clear picture of the market’s size and growth.

While Mattel (NASDAQ: MAT) has historically been the dominant player in the doll market – owing to established brands like Barbie and newer, still-growing brands like Monster High, as well as temporarily hot but nevertheless exciting successes linked to Disney Princess brands like Frozen – their mainstay brand Barbie has been in significant decline since 2012 according to retailer panel data compiled by mass retail analyst firm Klosters Trading Corporation. Private company MGA Entertainment, known for their Bratz, Moxie Girlz, Rescue Pets plushies and lifelike baby dolls marketed through a partnership with Zapf Creation (ETR/FRA: ZPFK), has also seen substantial decline in recent years according to the Klosters data, clearly telegraphing how fragmented the doll market has become, a phenomena which has opened up substantial room for newer brands and concepts to grow and flourish.

One such company is One World Holdings, Inc. (OTC: OWOO), whose Prettie Girls! brand, developed and marketed under their subsidiary known as The One World Doll Project, continues to capture attention and retail space in the attractive and still niche market for ethnically diverse dolls, a segment that has been routinely, yet unsuccessfully courted by major sector players. The most recent example of how ham-fisted major players like Mattel have been in this area is the PR nightmare surrounding their Mexico-inspired Barbie for their “Dolls of the World” collection, which was lampooned by the media and consumers alike as essentially being a cynical cash-grab that reinforces a negative stereotype of Mexican women, with the doll wearing a fiesta dress, sporting a pink passport, and carrying a pet Chihuahua. The subsequent attempt to salvage their reputation by changing the doll to Mariachi Barbie has not met with the hoped-for success and this fiasco demonstrates the lack of savvy major doll market players have had when it comes to appealing to not only an increasingly ethnically diverse American population, but to global markets, where young girls seek role models they can identify with.

The Prettie Girls! brand on the other hand has won fast favor with consumers and industry players alike, stealing the show at the 112th North American International Toy Fair due to the well-defined characteristics and personalities of each doll, which, while being ethnically diverse, are not focused on that ethnicity so much as on the wonderful and inspiring personalities crafted for each doll. This ingenious and adept approach was masterminded by OWOO’s Stacey McBride-Irby, who used to be a project designer at Mattel and developed the sorority Barbie modeled on the first African-American Greek Sorority, Alpha Kappa Alpha, before leaving Mattel after a 15-year run in order to make dolls which fully live up to her motto that a “happy, inspired childhood creates happy, inspired, and powerful women.”

Part of the success at Toy Fair 2015 for OWOO was the introduction of the tween versions of the company’s Prettie Girls! brand, the Tween Scene dolls, which are aimed at directly representing preteen girls and bringing an array of even more approachable, ethnically diverse role models to younger girls. Also at the Toy Fair, OWOO received confirmation from the Walmart.com buying team that sales performance of their Prettie Girls! brand was quite positive and that the brand would be featured in Walmart’s Easter sales promotion, as well as via the Walmart.com special offers program for approved members. Similar retail deals have given the company a sizeable retail footprint already, with a distribution agreement between OWOO and online sales giant Amazon.com having recently been signed, and the Prettie Girls! brand finding their way onto shelves at such popular brick and mortar retailers as Toys “R” Us, which has over 870 stores in the U.S. and more than 725 stores worldwide, as well as at Texas-based H-E-B Grocery, which has over 350 stores across Texas and northern Mexico.

Rather than cynically pandering to various ethnicities, the Prettie Girls! and Prettie Girls! Tween Scene brands lovingly cater to the ambitions, career goals and positive values all girls should aspire to, celebrating the ethnic diversity and fashion style of each highly unique doll, but not in a heavy-handed way that ultimately turns consumers off. With characteristics like an emphasis on participating in after-school activities and clubs, or desire to help their communities, as well as getting good grades and taking their futures seriously, this brand of dolls is light years beyond the state of design on offer from the major players in the industry. These revolutionary design elements make OWOO a company investors should keep their eye on, especially as the company moves to further flesh out their growing retail footprint with promotional efforts like games and cartoon shows based on the dolls.

With a 532% YoY jump in revenues reported for fiscal year 2014, OWOO has proven that their mix of intelligent brand design and marketing efforts focused on media venues frequented by their core target demographics is a successful blend of product and presence.

Take a closer look by visiting www.oneworlddolls.com

Let us hear your thoughts: One World Holdings Message Board

The International Energy Agency (IEA) today projected that slowing North American oil production will cause non-OPEC supply growth to slow in 2015, though the agency raised its yearly forecasts of non-OPEC oil supply growth by 200,000 p/d to 830,000 p/d compared to last months’ report.

According to James Ketner, president and CEO Galenfeha, a manufacturer of chemical injection systems and other low environmental impact products, falling rig counts and balanced production levels means more oil producers are seeking efficiency. It also means potentially more business for the Texas-based company and its newest product.

“Although we have seen a reduction in exploration rig count over the last six months, production levels are remaining the same,” Ketner said in a recent statement. “This tells us that U.S. efficiency is on the rise. Shale producers have asked us to help them cut costs, and this latest addition to our product line helps meet these goals. We are happy to be directly assisting producers reduce costs while increasing production efficiency levels.”

Oil and gas producers are increasingly interested in efficient operations that minimize environmental impact – a feasible goal via a reduction in chemicals and highly accurate production.

Previous chemical injection methods are dated, operating similarly to the drip gas fuel delivery techniques of the early automotive industry. Galenfeha, however, has introduced a new and cutting-edge component to the nearly $1 billion North American chemical injection market.

Galenfeha’s recently launched intelligent chemical injection control system, iWaV, is comparable to modern, state-of-the-art computer controlled fuel injection systems. The product is an innovative supervisor control and data acquisition (SCADA) system specifically created for the control of chemical injection pumps.

Computer-controlled and highly reliable, the iWaV system enables optimization and management of production controls and is scalable for any size of operation, from remote stand-alone sites, allowing two-way communications with pumps and complete control of the entire system.

The result is lower monitoring and controlling costs throughout the pumping cycle, and highly efficient and cost effective well site management.

Galenfeha introduced the iWaV in late March 2015 and currently markets, services and sells the individual and complete systems via direct sales as well as established relationships with local and national distribution partners.

For more information, visit www.galenfeha.com

Let us hear your thoughts: Galenfeha, Inc. Message Board

Online retail revenue saw an 11 percent year-over-year growth rate for the first quarter of 2014, and online shopping retail sales are predicted to continue to grow steadily, reaching $370 billion domestically in 2017. These statistics, which come from Adobe’s CMO.com, highlight the massive growth potential available for companies within the ecommerce sector. Mobile Lads Corp. (OTCBB: MOBO), through its acquisition of Simbadeals.com, is in a strong position to capitalize on this potential, providing nearly limitless opportunity for expansion in the years to come.

Simbadeals gives shoppers the freedom to browse a wide variety of products from some of the world’s most sought-after brands. Leveraging existing partnerships with major retailers including Walmart, Sears Canada, Macy’s, Canon, Banana Republic and others, the site provides consumers with discounts of up to 80 percent as compared to the prices of competitors. By driving traffic with the aim of converting sales, Mobile Lads will receive up to 15 percent of all merchandise sales made through the website moving forward.

Unlike other online shopping destinations, Simbadeals is built upon a strong business model that incorporates a win/win structure for both consumers and retailers. Consumers receive access to brand name products at heavily discounted prices, while retailers are able to list items for no cost, only paying a commission on sales through the site. By placing all responsibility for payments, shipping, returns and fulfillment directly on the retailer, Mobile Lads maintains a significant revenue stream without the financial risks regularly associated with the retail industry. With access to over 400 blue chip retailers already on the United States site, Simbadeals is a scalable solution that provides Mobile Lads with potentially massive growth opportunity.

In 2014, online sales accounted for an impressive eight percent of total retail sales. According to a report by The American Genius, this number is expected to rise to as much as 11 percent by the end of this year. Through the acquisition of Simbadeals, as well as the continued development of complementary services such as Coubox, Mobile Lads is in a good position to capitalize on the booming industry.

Get more info on Mobile Lads by visiting www.mobilelads.com

Let us hear your thoughts: Mobile Lads Corp. Message Board